Enhanced Lincomycin Titer Through Knockout of GntR Family Regulator SLCG_2790 Combined With Fermentation Optimization in an Industrial Strain of Streptomyces lincolnensis L‐427
Biotechnology Journal · 2026
DOI: 10.1002/biot.70173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Yinxu Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Streptomyces, Lincomycin, Bacterial Proteins. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Taishan Scholars Program of Shandong Province, Shanghai Pilot Program for Basic Research.
Abstract (Originalsprache)
In this study, lincomycin A (Lin‐A), a lincosamide antibiotic primarily synthesized by Streptomyces lincolnensis , was selected as a model to demonstrate a combined genetic regulation and process engineering strategy for production improvement. The GntR‐family transcriptional regulator SLCG_2790 was identified as a negative modulator of Lin‐A biosynthesis. Disruption of SLCG_2790 in the industrial strain S. lincolnensis L‐427 led to enhanced Lin‐A accumulation, accompanied by increased transcriptional levels of mycothiol and ergothioneine biosynthesis genes. Metabolic flux analysis revealed an 83.6% elevation in pentose phosphate pathway activity compared to the parental strain. Despite the observed reduction in mycelial growth resulting from SLCG_2790 deletion, fermentation performance was significantly improved through medium optimization using Plackett–Burman design, steepest ascent, and response surface methodology. The optimized conditions yielded a 38.1% increase in Lin‐A production in shake‐flask culture, along with an accelerated onset of physiological activity. In a 5‐L bioreactor, the engineered strain achieved a maximum Lin‐A titer of 3640.6 mg/L, representing a 101.4% improvement over the parental strain cultured in the original medium. These findings underscore the potential of transcriptional regulation coupled with rational process optimization to overcome metabolic constraints and enhance antibiotic production in actinomycetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
- HEC Pharm Co Ltd, Yichang, China.
ORCID-Profile: Yinxu Zhao, Feng Xu, Xiwei Tian
Förderung
- National Key Research and Development Program of China
- Taishan Scholars Program of Shandong Province
- Shanghai Pilot Program for Basic Research
- Shanghai Science and Technology Innovation Action Plan
- Fundamental Research Funds for the Central Universities
- Arawana Charity Foundation
Zitieren
APA
Zhao, Y., Xu, F., Shang, Q., Li, F., Yu, Z., Tian, X., & Chu, J. (2026). Enhanced Lincomycin Titer Through Knockout of GntR Family Regulator SLCG_2790 Combined With Fermentation Optimization in an Industrial Strain of Streptomyces lincolnensis L‐427. Biotechnology Journal. https://doi.org/10.1002/biot.70173
Vancouver
Zhao Y, Xu F, Shang Q, Li F, Yu Z, Tian X, et al. Enhanced Lincomycin Titer Through Knockout of GntR Family Regulator SLCG_2790 Combined With Fermentation Optimization in an Industrial Strain of Streptomyces lincolnensis L‐427. Biotechnology Journal. 2026. doi:10.1002/biot.70173
BibTeX
@article{Zhao2026,
author = {Zhao, Yinxu and Xu, Feng and Shang, Qinghai and Li, Feng and Yu, Zhenhua and Tian, Xiwei and Chu, Ju},
title = {Enhanced Lincomycin Titer Through Knockout of GntR Family Regulator SLCG_2790 Combined With Fermentation Optimization in an Industrial Strain of Streptomyces lincolnensis L‐427},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70173}
}
EUVIMED